[MP 12,465] SCHEDULE 1 (Regulation 3)GENERAL SALE MEDICINES

Antacids, when prepared as liquids, tablets and granules that do not contain a substance specified in schedules 2 to 10.

Antiseptics for use on the skin, when prepared as liquids, creams and sprays that do not contain a substance specified in schedules 2 to 10.

Castor oil.

Cod liver oil.

Complementary medicines that do not contain a substance specified in schedules 2 to 10, provided the labelling requirements and storage conditions recommended for such products are strictly complied with.

Cough preparations containing natural products that do not contain a substance specified in schedules 2 to 10.

Ear drops in packs of 15 ml or less that do not contain a substance specified in schedules 2 to 10.

Eucalyptus oil—

  • (a)when packed in containers having a nominal capacity of 15 ml or less fitted with a restricted flow insert, and labelled with the warnings—
    • (i)“KEEP OUT OF REACH OF CHILDREN”; and
    • (ii)“NOT TO BE TAKEN”;
  • (b)when packed in containers having a nominal capacity of 25 ml or less fitted with a restricted flow insert and child-resistant closure, and labelled with the warnings—
    • (i)“KEEP OUT OF REACH OF CHILDREN”; and
    • (ii)“NOT TO BE TAKEN”; or
  • (c)in preparations containing 25 per cent or less of eucalyptus oil.

Eye drops, sterile, in packs of 15 ml or less that do not contain a substance specified in schedules 2 to 10.

Eye lotions, sterile, in packs of 150 ml or less that do not contain a substance specified in schedules 2 to 10.

Glycerol (glycerine).

Lozenges and pastilles that do not contain a substance specified in schedules 2 to 10.

Lucca oil.

Magnesium sulfate (epsom salts).

Medicines for use on the skin that do not contain a substance specified in schedules 2 to 10.

Mouthwashes that do not contain a substance specified in schedules 2 to 10.

Paracetamol for therapeutic use—

  • (a)except when included in schedules 2, 3 or 4;
  • (b)in tablets or capsules each containing 500 mg or less of paracetamol as the only therapeutically active constituent other than effervescent agents, when—
    • (i)packed in blister or strip packaging or in containers with child-resistant closures;
    • (ii)in a primary pack containing not more than 100 such tablets or capsules;
    • (iii)the primary pack is labelled with the statements to the following effect—
      • (A)“ADULTS — KEEP TO THE RECOMMENDED DOSE. DO NOT TAKE THIS MEDICINE FOR LONGER THAN A FEW DAYS AT A TIME UNLESS ADVISED TO BY A DOCTOR”;
      • (B)“CHILDREN AND ADOLESCENTS — KEEP TO THE RECOMMENDED DOSE. DO NOT TAKE THIS MEDICINE FOR LONGER THAN 48 HOURS AT A TIME UNLESS ADVISED TO BY A DOCTOR”;
      • (C)“IF AN OVERDOSE IS SUSPECTED, RING A DOCTOR OR GO TO A HOSPITAL STRAIGHT AWAY EVEN IF YOU FEEL WELL BECAUSE OF THE RISK OF DELAYED, SERIOUS LIVER DAMAGE”;
      • (D)“DO NOT TAKE WITH OTHER PRODUCTS CONTAINING PARACETAMOL, UNLESS ADVISED TO DO SO BY A DOCTOR OR PHARMACIST”; and
    • (iv)not labelled for the treatment of children 6 years of age or less.

Potassium acid tartrate (cream of tartar).

Potassium nitrate (saltpetre).

Senna.

Sodium bicarbonate.

Sodium carbonate.

Sodium sulfate (glauber salts).

Sulfur.

Toothache drops in packs of 15 ml or less that do not contain a substance specified in schedules 2 to 10.